Syddansk Universitet Evidence of perturbed germinal center dynamics , but preserved antibody diversity , in end-stage renal disease

[1]  U. Klein,et al.  Dynamics of B cells in germinal centres , 2015, Nature Reviews Immunology.

[2]  Anders Blaabjerg Lange,et al.  Sterile DJH Rearrangements Reveal that Distance Between Gene Segments on the Human Ig H Chain Locus Influences Their Ability To Rearrange , 2015, The Journal of Immunology.

[3]  H. Ueno,et al.  Pathophysiology of T follicular helper cells in humans and mice , 2015, Nature Immunology.

[4]  Jerome H. Kim,et al.  Loss of Circulating CD4 T Cells with B Cell Helper Function during Chronic HIV Infection , 2014, PLoS pathogens.

[5]  Daphne Koller,et al.  The Effects of Somatic Hypermutation on Neutralization and Binding in the PGT121 Family of Broadly Neutralizing HIV Antibodies , 2013, PLoS pathogens.

[6]  C. Mackay,et al.  Circulating precursor CCR7(lo)PD-1(hi) CXCR5⁺ CD4⁺ T cells indicate Tfh cell activity and promote antibody responses upon antigen reexposure. , 2013, Immunity.

[7]  S. Zakynthinos,et al.  CXCL13 production in B cells via Toll-like receptor/lymphotoxin receptor signaling is involved in lymphoid neogenesis in chronic obstructive pulmonary disease. , 2013, American journal of respiratory and critical care medicine.

[8]  A. Grzegorzewska.  Hepatitis B Vaccination in Chronic Kidney Disease: Review of Evidence in Non-Dialyzed Patients , 2012, Hepatitis monthly.

[9]  N. Vaziri.  CKD impairs barrier function and alters microbial flora of the intestine: a major link to inflammation and uremic toxicity , 2012, Current opinion in nephrology and hypertension.

[10]  Thomas Pradeu,et al.  The danger theory: 20 years later , 2012, Front. Immun..

[11]  A. Baíllo,et al.  EBI2 regulates CXCL13‐mediated responses by heterodimerization with CXCR5 , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[12]  M. Fischl,et al.  Impaired peripheral blood T-follicular helper cell function in HIV-infected nonresponders to the 2009 H1N1/09 vaccine. , 2012, Blood.

[13]  J. Browning,et al.  Regulation of TH2 development by CXCR5+ dendritic cells and lymphotoxin-expressing B cells , 2012, Nature Immunology.

[14]  C. Kotton.  Vaccinations in kidney transplant patients: searching for optimal protection. , 2011, American Society of Nephrology. Clinical Journal.

[15]  M. Betjes,et al.  Premature aging of circulating T cells in patients with end-stage renal disease. , 2011, Kidney international.

[16]  C. Mackay,et al.  CXCR5 Expressing Human Central Memory CD4 T Cells and Their Relevance for Humoral Immune Responses , 2011, The Journal of Immunology.

[17]  H. Ueno,et al.  Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. , 2011, Immunity.

[18]  W. Pomat,et al.  Genomic screening by 454 pyrosequencing identifies a new human IGHV gene and sixteen other new IGHV allelic variants , 2011, Immunogenetics.

[19]  M. Peakman,et al.  Evolution of Ectopic Lymphoid Neogenesis and In Situ Autoantibody Production in Autoimmune Nonobese Diabetic Mice: Cellular and Molecular Characterization of Tertiary Lymphoid Structures in Pancreatic Islets , 2010, The Journal of Immunology.

[20]  P. Stenvinkel,et al.  Inflammation in End‐Stage Renal Disease—What Have We Learned in 10 Years? , 2010, Seminars in dialysis.

[21]  C. Katlama,et al.  Cellular CD4 T cell responses to the diphtheria-derived carrier protein of conjugated pneumococcal vaccine and antibody response to pneumococcal vaccination in HIV-infected adults. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  M. Haubitz,et al.  B-cell-attracting chemokine CXCL13 as a marker of disease activity and renal involvement in systemic lupus erythematosus (SLE). , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[23]  N. Vaziri,et al.  Effect of end-stage renal disease on B-lymphocyte subpopulations, IL-7, BAFF and BAFF receptor expression , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[24]  Michael Meyer-Hermann,et al.  University of Birmingham Deriving a germinal center lymphocyte migration model from two-photon data , 2008 .

[25]  P. Rácz,et al.  Altered expression of the receptor-ligand pair CXCR5/CXCL13 in B cells during chronic HIV-1 infection. , 2008, Blood.

[26]  M. Klinger,et al.  IL-18 is involved in vascular injury in end-stage renal disease patients. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[27]  N. Litjens,et al.  Impaired immune responses and antigen-specific memory CD4+ T cells in hemodialysis patients. , 2008, Journal of the American Society of Nephrology : JASN.

[28]  I. Rioja,et al.  Potential novel biomarkers of disease activity in rheumatoid arthritis patients: CXCL13, CCL23, transforming growth factor alpha, tumor necrosis factor receptor superfamily member 9, and macrophage colony-stimulating factor. , 2008, Arthritis and rheumatism.

[29]  M. Keating,et al.  Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia. , 2007, Blood.

[30]  F. Re,et al.  Aluminum Hydroxide Adjuvants Activate Caspase-1 and Induce IL-1β and IL-18 Release1 , 2007, The Journal of Immunology.

[31]  M. Nielsen,et al.  No evidence for the use of DIR, D–D fusions, chromosome 15 open reading frames or VHreplacement in the peripheral repertoire was found on application of an improved algorithm, JointML, to 6329 human immunoglobulin H rearrangements , 2006, Immunology.

[32]  R. Foley,et al.  Clinical epidemiology of pneumonia in hemodialysis patients: the USRDS waves 1, 3, and 4 study. , 2006, Kidney international.

[33]  A. Ruello,et al.  Oxidative stress, sister chromatid exchanges and apoptosis in the pathogenesis of lymphocytopenia in ESRD patients. , 2006, JN. Journal of Nephrology (Milano. 1992).

[34]  David G. Schatz,et al.  Targeting of somatic hypermutation , 2006, Nature Reviews Immunology.

[35]  R. Detels,et al.  Serum levels of the homeostatic B cell chemokine, CXCL13, are elevated during HIV infection. , 2005, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[36]  C. Mackay,et al.  Follicular B helper T cells in antibody responses and autoimmunity , 2005, Nature Reviews Immunology.

[37]  H. Marquart,et al.  Deficiency of Somatic Hypermutation of Immunoglobulin G Transcripts Is a Better Predictor of Severe Respiratory Tract Infections than Lack of Memory B Cells in Common Variable Immunodeficiency , 2005, Journal of Clinical Immunology.

[38]  D. Tough,et al.  B-cell kinetics in humans: rapid turnover of peripheral blood memory cells. , 2005, Blood.

[39]  L. Qun,et al.  Selectively frequent expression of CXCR5 enhances resistance to apoptosis in CD8+CD34+ T cells from patients with T-cell-lineage acute lymphocytic leukemia , 2005, Oncogene.

[40]  A. Svejgaard,et al.  Deficiency of somatic hypermutation of the antibody light chain is associated with increased frequency of severe respiratory tract infection in common variable immunodeficiency. , 2005, Blood.

[41]  Randi Chen,et al.  Burden of infection in patients with end-stage renal disease requiring long-term dialysis. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[42]  E. S. Baekkevold,et al.  Monocyte-like and mature macrophages produce CXCL13 (B cell-attracting chemokine 1) in inflammatory lesions with lymphoid neogenesis. , 2004, Blood.

[43]  S. Ellenberg,et al.  A global perspective on vaccine safety and public health: the Global Advisory Committee on Vaccine Safety. , 2004, American journal of public health.

[44]  A. Osterhaus,et al.  Impaired response rates, but satisfying protection rates to influenza vaccination in dialysis patients. , 2004, Vaccine.

[45]  Silvano Sozzani,et al.  Distinct Transcriptional Programs Activated by Interleukin-10 with or without Lipopolysaccharide in Dendritic Cells: Induction of the B Cell-Activating Chemokine, CXC Chemokine Ligand 131 , 2004, The Journal of Immunology.

[46]  R. Kocabaş,et al.  Acute effect of hemodialysis on serum levels of the proinflammatory cytokines. , 2003, Mediators of inflammation.

[47]  G. Lizard.  Changes in light scatter properties are a general feature of cell death but are not characteristic of apoptotically dying cells. , 2001, Cytometry.

[48]  Jason G. Cyster,et al.  A chemokine-driven positive feedback loop organizes lymphoid follicles , 2000, Nature.

[49]  Nancy Trangmoe.  Tetanus immunization and its association to hepatitis B vaccination in patients with chronic renal failure , 1996 .

[50]  W. Szmuness,et al.  Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy. , 1984, The New England journal of medicine.

[51]  P. Li,et al.  Circulating endotoxemia: a novel factor in systemic inflammation and cardiovascular disease in chronic kidney disease. , 2011, Clinical journal of the American Society of Nephrology : CJASN.

[52]  P. in’t Veld.  Insulitis in human type 1 diabetes: The quest for an elusive lesion. , 2011, Islets.

[53]  G.,et al.  Annexin V for Flow Cytometric Detection of Phosphatidylserine Expression on B Cells Undergoing Apoptosis , 2000 .

[54]  R. Vanholder,et al.  Influence of uraemia and haemodialysis on host defence and infection. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.